← Open Payments lookup

AMY ARNDT: Open Payments

NPI 1407843048 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$312 in 21 payments from 8 companies in 2025. Trend: 2023 $439 · 2024 $614 · 2025 $312

Food & beverage: $312
CompanyPaymentsAmount
ABBVIE INC.12$159
Novo Nordisk Inc2$40
Otsuka America Pharmaceutical, Inc.2$35
Janssen Pharmaceuticals, Inc1$20
Azurity Pharmaceuticals, Inc.1$16
PFIZER INC.1$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14
AstraZeneca Pharmaceuticals LP1$14

Products named: VRAYLAR, REXULTI, UBRELVY, Wegovy, SPRAVATO, QULIPTA, Rybelsus, AZMIRO.

Industry payments across NE — which companies pay providers there.